Skip to main content
. 2022 Feb 10;13:760776. doi: 10.3389/fimmu.2022.760776

Figure 6.

Figure 6

Associations of changes in serum CHIT1 activity and YKL-40 concentration with changes in FVC% pred. in patients with the stable and progressive disease over the second year of antifibrotic treatment. Panels showing: (A) a correlation between changes in serum YKL-40 concentration levels and changes in FVC% pred. in the stables subgroup (n=15), (B) a correlation between changes in serum CHIT1 activity levels and changes in FVC% pred. in the progressors subgroup (n=10), FVC, forced vital capacity; CHIT1, chitotriosidase; YKL-40, chitinase 3-like-1.